Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Full-length optic nerve regeneration in the absence of genetic manipulations
Qian Feng, Kimberly A. Wong, Larry I. Benowitz
Qian Feng, Kimberly A. Wong, Larry I. Benowitz
View: Text | PDF
Research Article Inflammation Neuroscience

Full-length optic nerve regeneration in the absence of genetic manipulations

  • Text
  • PDF
Abstract

The inability of mature retinal ganglion cells (RGCs) to regenerate axons after optic nerve injury can be partially reversed by manipulating cell-autonomous and/or -nonautonomous factors. Although manipulations of cell-nonautonomous factors could have higher translational potential than genetic manipulations of RGCs, they have generally produced lower levels of optic nerve regeneration. Here, we report that preconditioning resulting from mild lens injury (conditioning LI, cLI) before optic nerve damage induced far greater regeneration than LI after nerve injury or the pro-inflammatory agent zymosan given either before or after nerve damage. Unlike zymosan-induced regeneration, cLI was unaltered by depleting mature neutrophils or T cells or blocking receptors for known inflammation-derived growth factors (oncomodulin, stromal cell–derived factor 1, CCL5) and was only partly diminished by suppressing CCR2+ monocyte recruitment. Repeated episodes of LI led to full-length optic nerve regeneration, and pharmacological removal of local resident macrophages with the colony stimulating factor 1 receptor inhibitor PLX5622 enabled some axons to reinnervate the brain in just 6 weeks, comparable to the results obtained with the most effective genetic manipulations of RGCs. Thus, cell-nonautonomous interventions can induce high levels of optic nerve regeneration, paving the way to uncovering potent, translatable therapeutic targets for CNS repair.

Authors

Qian Feng, Kimberly A. Wong, Larry I. Benowitz

×

Figure 5

Multiple LIs combined with PLX enables brain reinnervation.

Options: View larger image (or click on image) Download as PowerPoint
Multiple LIs combined with PLX enables brain reinnervation.
(A) Experime...
(A) Experimental timeline. Mice received PLX treatment for 2 weeks before first LI until euthanasia. Multiple LIs were administered accordingly. Mice were euthanized 6 weeks after ONC. (B) Upper panels: brain sections stained with anti-NeuN and anti-CTB antibodies. Lower panels display magnified images of the areas in white dashed boxes in A, showing regenerating axons entering the core of the suprachiasmatic nucleus (SCN, visualized by NeuN immunostaining). Both scale bars, 100 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts